NDA 211580 · Novadaq Tech
Spy Agent Green Kit
Indocyanine Green · Intravenous, Interstitial
Last checked: Nov 19, 2026Latest source record: Jun 5, 2023 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations
First approved
2018
Nov 21, 2018
Approved uses
2
Original approval plus efficacy supplements
Registered trials
249
28 Phase 3, 43 recruiting
FAERS reports
0
0 serious, 0 with death reported
AI brief across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.
What it is approved for
No structured label for this application in openFDA. Older and discontinued products often have none.
Approval history
Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.
- Jun 5, 2023 Supplement 6 · Efficacy LabelLetterLetter
- Nov 21, 2018 Original approval · Type 5 - New Formulation or New Manufacturer LabelLetterReview
1 products under this application
- SPY AGENT GREEN KIT · INDOCYANINE GREEN 25MG/VIAL · POWDER, INTRAVENOUS, INTERSTITIAL · Prescription
Clinical trials
Interventional ClinicalTrials.gov studies with "Indocyanine Green" as an intervention, any sponsor and status, largest first.
- The Use of Indocyanine Green Near-infrared Fluorescence for Bowel Perfusion Quantitative Assessment in Order to Prevent Anastomotic Leakage in Colorectal SurgeryPivotal-lookingNot yet recruiting
Vadim KuznetsovResearch network
NCT06845306 · 1,268 participants (planned) · Start Jun 1, 2025 · Primary completion Jul 1, 2026
Drug: ICG-guided bowel perfusion assessment · For: Colo-rectal Cancer; Colonic Neoplasms Malignant
Sites: Vsevolozhsk District, Russia
Isabelle HenskensAcademic, hospital or other
NCT07146295 · 1,150 participants (planned) · Start Apr 18, 2025 · Primary completion Feb 2027
Drug: Technetium (99mTc); Indocyanine Green · For: Breast Cancer; Sentinel Lymph Node Biopsy (SLNB); Sentinel Lymph Node Detection and 6 more
Sites: Alkmaar, Netherlands; Hengelo, Netherlands; Hoofddorp, Netherlands · 7 sites in all
- Intraoperative Indocyanine Green Fluorescence Angiography in Colorectal Surgery to Prevent Anastomotic LeakagePivotal-lookingStatus unknown
Centre Hospitalier Universitaire de BesanconAcademic, hospital or other
NCT05168839 · 1,010 participants (planned) · Start Sep 26, 2022 · Primary completion Oct 31, 2025
Drug: FLUO+ : Intraoperative fluorescence angiography (IOFA) with indocyanine green (ICG). · For: Colorectal Cancer
Sites: Amiens, France; Annecy, France; Besançon, France · 32 sites in all
- Anastomotic Leakage and Value Of Indocyanine Green in Decreasing Leakage RatesPivotal-lookingStatus unknown
Leiden University Medical CenterAcademic, hospital or other
NCT04712032 · 978 participants (planned) · Start Jul 1, 2020 · Primary completion Jul 1, 2022
Drug: ICG-guided bowel perfusion assessment · For: Colo-rectal Cancer; Crohn Disease; Resectable Colorectal Carcinoma
Sites: Leiden, Netherlands
- Fluorescence for Sentinel Lymph Node Identification in Cancer SurgeryPivotal-lookingCompleted
Institut de Cancérologie de LorraineAcademic, hospital or other
NCT02997553 · 744 participants · Start Nov 29, 2017 · Primary completion Sep 19, 2022
Drug: Indocyanine green; Technetium99 · For: Breast Carcinoma; Head and Neck Cancer; Melanoma (Skin) and 7 more
Sites: Vandœuvre-lès-Nancy, France
- NIFR Image-guided Surgery for Malignant Soft Tissue Tumor With Low-dose SWIG TechniquePivotal-lookingNot yet recruiting
The Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeAcademic, hospital or other
NCT06610071 · 592 participants (planned) · Start Oct 30, 2024 · Primary completion Dec 2028
Drug: ICG administration; ICG administration and 2 more · For: Dermatofibrosarcoma Protuberans (DFSP); Skin Squamous Cell Carcinoma
University of PennsylvaniaAcademic, hospital or other
NCT04723810 · 500 participants (planned) · Start Aug 14, 2024 · Primary completion Jan 14, 2027
Drug: Indocyanine Green · For: Tumor, Solid
Sites: Philadelphia, Pennsylvania
- Use of Indocyanine Green in Acute CholecystitisPivotal-lookingStatus unknown
Corporacion Parc TauliAcademic, hospital or other
NCT05709548 · 440 participants (planned) · Start Mar 15, 2023 · Primary completion Dec 2025
Drug: Indocyanine green · For: Acute Cholecystitis; Bile Duct Injury
Sites: Sabadell, Spain; Vic, Spain
Most reported adverse reactions
FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.
No FAERS reports name this application.
FAERS reports by year
By the date FDA received the report.
No reports.
Recalls
0 FDA enforcement reports for this application.
No recalls on record for this application.
Shortages
FDA's drug shortage list.
Not on FDA's shortage list.
Medicare spending
CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.
Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.
Published evidence
PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.
- Indocyanine Green Fluorescence Imaging in Prevention of Colorectal Anastomotic Leakage: A Randomized Clinical Trial.
Rinne JKA, Huhta H, Pinta T, et al. · JAMA Surg 2025 · Multicenter Study, Randomized Controlled Trial
- Biophotonics-Intraoperative Guidance During Partial Nephrectomy: A Systematic Review and Meta-analysis.
Egen L, Demmel GS, Grilli M, et al. · Eur Urol Focus 2024 · Systematic Review, Meta-Analysis
- Blood Perfusion Assessment by Indocyanine Green Fluorescence Imaging for Minimally Invasive Rectal Cancer Surgery (EssentiAL trial): A Randomized Clinical Trial.
Watanabe J, Takemasa I, Kotake M, et al. · Ann Surg 2023 · Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- A meta-analysis of the efficacy and safety of indocyanine green fluorescence imaging-guided laparoscopic cholecystectomy.
Tang J, Wu T, Yang L, et al. · Photodiagnosis Photodyn Ther 2025 · Meta-Analysis, Systematic Review
- Indocyanine green fluorescence-guided surgery in head and neck cancer: A systematic review.
De Ravin E, Venkatesh S, Harmsen S, et al. · Am J Otolaryngol 2022 · Systematic Review
- Effects of remote ischemic preconditioning in hepatectomy: a systematic review and meta-analysis.
Tian C, Wang A, Huang H, et al. · BMC Anesthesiol 2024 · Meta-Analysis, Systematic Review
Sponsor: Novadaq Tech
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.